Search results
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
Scarborough Advisors LLC Takes $1.38 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoScarborough Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 8,907 shares of ...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via AOL· 4 days agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
FOX 23 News Albany· 3 days agoThis offer is conditioned on, among other things, the closing price per share of AbbVie's common...
AbbVie inks deal to develop new IBD therapy with FutureGen By Investing.com
Investing.com· 4 days agoFG-M701, which is currently in the preclinical development stage, is designed as a fully human...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
2 Dividend Stocks That Could Pay You for Life
The Motley Fool via AOL· 21 hours agoThough many income stocks will eventually have to suspend or decrease their dividends, some seem solid enough to pay investors for a lifetime. Let's...
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
Benzinga via Yahoo Finance· 4 days agoWith 52 consecutive years of dividend growth and a dividend yield of over 3.6%, AbbVie Inc....
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 3 days agoAbbVie has made a licence agreement with FutureGen Biopharmaceutical to develop a next-generation...